Macconi, L.; Galici, V.; Di Maurizio, M.; Rossi, E.; Taccetti, G.; Terlizzi, V.
Early Effects of Elexacaftor-Tezacaftor-Ivacaftor Therapy on Magnetic Resonance Imaging in Patients with Cystic Fibrosis and Advanced Lung Disease. J. Clin. Med. 2022, 11, 4277.
https://doi.org/10.3390/jcm11154277
AMA Style
Macconi L, Galici V, Di Maurizio M, Rossi E, Taccetti G, Terlizzi V.
Early Effects of Elexacaftor-Tezacaftor-Ivacaftor Therapy on Magnetic Resonance Imaging in Patients with Cystic Fibrosis and Advanced Lung Disease. Journal of Clinical Medicine. 2022; 11(15):4277.
https://doi.org/10.3390/jcm11154277
Chicago/Turabian Style
Macconi, Letizia, Valeria Galici, Marco Di Maurizio, Enrica Rossi, Giovanni Taccetti, and Vito Terlizzi.
2022. "Early Effects of Elexacaftor-Tezacaftor-Ivacaftor Therapy on Magnetic Resonance Imaging in Patients with Cystic Fibrosis and Advanced Lung Disease" Journal of Clinical Medicine 11, no. 15: 4277.
https://doi.org/10.3390/jcm11154277
APA Style
Macconi, L., Galici, V., Di Maurizio, M., Rossi, E., Taccetti, G., & Terlizzi, V.
(2022). Early Effects of Elexacaftor-Tezacaftor-Ivacaftor Therapy on Magnetic Resonance Imaging in Patients with Cystic Fibrosis and Advanced Lung Disease. Journal of Clinical Medicine, 11(15), 4277.
https://doi.org/10.3390/jcm11154277